Detalhe da pesquisa
1.
Cellular Therapy in NSCLC: Between Myth and Reality.
Curr Oncol Rep
; 25(10): 1161-1174, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646900
2.
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
Curr Oncol Rep
; 25(8): 913-922, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249833
3.
Neoadjuvant Immunotherapy: A Promising New Standard of Care.
Int J Mol Sci
; 24(14)2023 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511609
4.
Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with Chemotherapy.
Cancer Invest
; 40(5): 406-412, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34409906
5.
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.
Curr Oncol Rep
; 24(12): 1851-1862, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255605
6.
SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2.
Cancer Immunol Immunother
; 70(5): 1255-1262, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130956
7.
The Role and Impact of Minimal Residual Disease in NSCLC.
Curr Oncol Rep
; 23(12): 136, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735646
8.
A New Generation of Vaccines in the Age of Immunotherapy.
Curr Oncol Rep
; 23(12): 137, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735649
9.
The METeoric rise of MET in lung cancer.
Cancer
; 126(22): 4826-4837, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888330
10.
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort.
Cancer Immunol Immunother
; 69(8): 1605-1613, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32307579
11.
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
Acta Oncol
; 59(9): 1058-1063, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762415
12.
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Int J Mol Sci
; 21(17)2020 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878298
13.
[A new hope in the treatment of hepatocellular carcinoma]. / Nouveaux espoirs thérapeutiques dans le carcinome hépatocellulaire.
Rev Med Suisse
; 16(695): 1074-1078, 2020 May 27.
Artigo
em Francês
| MEDLINE | ID: mdl-32462834
14.
[Metastatic hormone-sensitive prostate cancer: more than just androgen-deprivation therapy]. / Cancer de la prostate métastatique hormonosensible: l'hormonothérapie, oui, mais pas seulement !
Rev Med Suisse
; 16(695): 1098-1101, 2020 May 27.
Artigo
em Francês
| MEDLINE | ID: mdl-32462838
15.
[Granulocyte-Colony Stimulating Factors as adjunctive therapy in patients with neutropenic fever]. / Facteurs de croissance granulocytaire dans le traitement curatif des neutropénies fébriles.
Rev Med Suisse
; 16(711): 1995-2000, 2020 Oct 21.
Artigo
em Francês
| MEDLINE | ID: mdl-33085256
16.
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients.
Breast Cancer Res Treat
; 174(3): 775-783, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635808
17.
Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era.
Curr Oncol Rep
; 21(12): 107, 2019 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768759
18.
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC.
Curr Treat Options Oncol
; 20(10): 79, 2019 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31482479
19.
[Supportive care in oncology: a real change for patients?] / Soins de support en oncologie : un vrai changement pour le patient ?
Rev Med Suisse
; 13(563): 1049-1051, 2017 May 17.
Artigo
em Francês
| MEDLINE | ID: mdl-28636297
20.
ADAURA: Mature Enough for Publication, Not for Prime Time.
Oncologist
; 26(4): 266-268, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314452